Indaptus Therapeutics, Inc. (INDP)

Nasdaq: INDP · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2021

Full chart Alerts Compare

Grade4.3

◀ Past 4.0● Present 2.0▶ Future 6.4

6 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Who owns Indaptus Therapeutics, Inc.

As filed with the SEC

Holders of 5% or more

Lazar David E. holds 47.9% of Common Stock, $0.01 par value, as its SCHEDULE 13D/A filed Mar 24, 2026 says.

Directors and officers

report now, of 21 people on the record since 2021. Their holdings as a group are not read here.

Institutions as a whole

n/a

The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.

Holders of 5% or moreshare of the class, as filed

Lazar David E.

SCHEDULE 13D/A · filed Mar 24, 2026 · Common Stock, $0.01 par value · 98% in Mar 2, 2026

47.9%

Yao Yun

SCHEDULE 13D/A · filed Oct 22, 2026 · Common Stock, par value $0.01 per share · 31.5% in Jun 26, 2026

27.3%

Sino Lion Ventures Ltd

SCHEDULE 13D/A · filed Oct 22, 2026 · Common Stock, par value $0.01 per share · 29.2% in Jun 26, 2026

25.3%

Jeffery A. Meckler

SCHEDULE 13D/A · filed Dec 30, 2025 · Common Stock, $0.01 par value per share

12.7%

Dai Junyi

SCHEDULE 13D/A · filed Oct 22, 2026 · Common Stock, par value $0.01 per share · 8.44% in Jun 26, 2026

7.33%

Yang Ting

SCHEDULE 13D/A · filed Oct 21, 2026 · Common Stock, par value $0.01 per share · 8.44% in Jun 26, 2026

6.48%

Newman Michael James

SCHEDULE 13D/A · filed Dec 30, 2025 · Common Stock, Par Value $0.01 Per Share

5.4%

YA II PN, Ltd.

SCHEDULE 13G/A · filed Apr 6, 2026 · Common Stock · reported falling below 5%, from 9.99% in Feb 18, 2025

under 5%

What INDP reports owning in othersstakes of 5% or more, and other ties

Other ties the annual report names

Yorkville

An entity · legal entity · owns, named in the 10-K filed Mar 17, 2026

Insider tradesForm 4

0sales

0purchases

0sales on a scheduled plan

0people selling

$0sold, in dollars

$0bought, in dollars

Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.

By calendar yearSoldBought

2122

2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.

People who traded in the window

No one on the roster filed an open-market trade in the window.

SI Assistanton INDP · research, not advice